HUTCHMED (China) Limited (HK:0013) has released an update.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
HUTCHMED (China) Limited has announced its blocklisting six monthly return, highlighting that during the period from June to December 2024, 241,375 ordinary shares were issued under the 2015 Share Option Scheme. The company, known for its innovative cancer and immunology therapies, maintains a robust pipeline with 871,601,095 shares currently in issue.
For further insights into HK:0013 stock, check out TipRanks’ Stock Analysis page.
